Role of Early Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Diagnosing Non-Resolving Pneumonia at a Tertiary Care Hospital
- 1. Post Graduate Student, Department of Respiratory Medicine, Pt. J. N. M. Medical College and Dr. B.R.A.M Hospital, Raipur
- 2. Professor and HOD, Department of Respiratory Medicine, Pt. J. N. M. Medical College and Dr. B.R.A.M Hospital, Raipur
- 3. Associate Professor, Department of Respiratory Medicine, Pt. J. N. M. Medical College and Dr. B.R.A.M Hospital, Raipur
Description
Pneumonia, a significant cause of morbidity and mortality globally, often presents diagnostic challenges due to unidentified etiologic agents. Non-resolving pneumonia, particularly, complicates clinical management, as standard antibiotic therapy may be ineffective. This study aimed to investigate the role of early bronchoscopy and bronchoalveolar lavage (BAL) in identifying causative agents in patients with non-resolving pneumonia at a tertiary care hospital. This observational cross-sectional study, conducted at DR. BRAMH, Raipur, from January 2023 to February 2024, included 140 patients presenting with pneumonia symptoms and radiographic findings. Fiberoptic bronchoscopy was performed on all participants, with BAL samples analyzed for bacterial, fungal, and mycobacterial pathogens. Histopathological biopsies were conducted whererever necessary. The study identified pathogenic organisms in 86.43% of cases, with Pseudomonas aeruginosa (40.71%) and Klebsiella pneumoniae (21.43%) as the predominant pathogens. Notably, malignancies were detected in 13.57% of cases, with squamous cell carcinoma being most common. Bronchoscopy findings indicated mucosal inflammation in 80.71% and endobronchial masses in 12.86% of patients. The results emphasize the diagnostic importance of early bronchoscopy and BAL in non-resolving pneumonia, allowing for tailored treatments and potentially improved patient outcomes. This study supports the integration of bronchoscopy in managing complex pneumonia cases to address diagnostic gaps and treatment challenges, ultimately aiming to reduce mortality in this patient population.
Abstract (English)
Pneumonia, a significant cause of morbidity and mortality globally, often presents diagnostic challenges due to unidentified etiologic agents. Non-resolving pneumonia, particularly, complicates clinical management, as standard antibiotic therapy may be ineffective. This study aimed to investigate the role of early bronchoscopy and bronchoalveolar lavage (BAL) in identifying causative agents in patients with non-resolving pneumonia at a tertiary care hospital. This observational cross-sectional study, conducted at DR. BRAMH, Raipur, from January 2023 to February 2024, included 140 patients presenting with pneumonia symptoms and radiographic findings. Fiberoptic bronchoscopy was performed on all participants, with BAL samples analyzed for bacterial, fungal, and mycobacterial pathogens. Histopathological biopsies were conducted whererever necessary. The study identified pathogenic organisms in 86.43% of cases, with Pseudomonas aeruginosa (40.71%) and Klebsiella pneumoniae (21.43%) as the predominant pathogens. Notably, malignancies were detected in 13.57% of cases, with squamous cell carcinoma being most common. Bronchoscopy findings indicated mucosal inflammation in 80.71% and endobronchial masses in 12.86% of patients. The results emphasize the diagnostic importance of early bronchoscopy and BAL in non-resolving pneumonia, allowing for tailored treatments and potentially improved patient outcomes. This study supports the integration of bronchoscopy in managing complex pneumonia cases to address diagnostic gaps and treatment challenges, ultimately aiming to reduce mortality in this patient population.
Files
IJPCR,Vol16,Issue11,Article137.pdf
Files
(294.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ff1aa772c08bd4c19f4d6f94a8b96430
|
294.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-10-26
Software
- Repository URL
- http://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue11,Article137.pdf
- Development Status
- Active
References
- 1. Steel HC, Cockeran R, Anderson R, Feldman C. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013; 2013:490346. 2. Ramesh PM, Saravanan M. A clinical study on non-resolving pneumonia in tertiary care centre. Int J Adv Med 2018; 5:604-7. 3. Arancibia F, Ewig S, Martinez J A, Ruiz M, Bauer T, Marcos M A, et al. Antimicrobial treatment failures in patients with community acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000; 162:154-160. 4. Fein AM, Feinsilver SH. The approach to nonresolving pneumonia in the elderly. Semin Respir Infect. 1993; 28:726-29. 5. Daniels JMA. Flexible bronchoscopy. In: Herth FJF, Shah PL, Gompelmann D, editors. Interventional Pulmonology [ERS Monograph] Sheffield: European Respiratory Society; 2017:1–18. 6. Daniels JMA. Flexible bronchoscopy. In: Herth FJF, Shah PL, Gompelmann D, editors. Interventional Pulmonology [ERS Monograph] Sheffield: European Respiratory Society; 2017:1–18. 7. Weyers CM, Leeper KV. Non-resolving pneumonia, Clin. Chest Med. 2005; 26:143– 58. 8. Pasha MM, Vinod K, Salimath SS, Halappa S. Evaluation of diagnostic outcomes of nonresolving pneumonia by fiberopticbronchoscopy. IP Indian Journal of Immunology and Respiratory Medicine. 2023 Jan 24; 3(2):56-60. 9. Chaudhuri AD, Mukherjee S, Nandi S, Bhuniya S, Tapadar SR, Saha M. A study on non-resolving pneumonia with special reference to role of fiberoptic bronchoscopy. Lung India. 2013 Jan 1; 30(1):27-32. 10. Kirtland SH, Winterbauer RH ―Slowly resolving, chronic, and recurrent pneumoniaǁ Clin Chest Med. 1991 Jun; 12(2):303-18. 11. Avijgan M. Specificity and sensitivity of clinical diagnosis for chronic pneumonia. East Mediterr Health J. 2005; 11:1029–37. 12. Boyd DH. Failure of resolution. Br J Dis Chest. 1975; 69:259–66. 13. Begamy T. Thoracic empyema. Is its microbiology changing? Pul Rev Com. 2000; 5:10–2.